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ABSTRACT: 
BACKGROUND: In an era where successful renal transplantation can be offered to a 
growing number of patients, there is an increasing concern about the complications 
that develop after the transplantation of a functioning allograft. One of the most 
significant complications in this setting is new-onset diabetes after transplantation 
(NODAT) as it is the major factor leading to dysfunction of the renal graft and patient 
death and is a risk factor for cardiovascular disease in these patients. The mechanism 
behind the development of NODAT is poorly understood and is possible that a similar 
pathogenesis occurs to that of Type2 diabetes, but differs in being partially reversible 
because of the associated immunosuppressive medication. There are various risk 
factors contributing to NODAT and are categorized into Non modifiable, Potentially 
modifiable and modifiable. The incidences of infections were reported to be high in 
patients with NODAT. 
AIMS AND OBJECTIVES: To study the prevalence of NODAT among the patients 
who underwent renal transplantation and to assess the relevant risk factors 
contributing to the pathogenesis of NODAT. And also to study the complications that 
develop in patients diagnosed with NODAT and the difference in pattern of NODAT 
between live related and deceased donor transplant recipients 
MATERIALS AND METHODS: The study was carried out by retrospective 
analysis of the data of patients who underwent renal transplantation in Stanley medical 
college from January 2012 to December 2014. The following data : Smoking history, 
family history of Diabetes, native kidney disease, type of Dialysis, duration of 
Dialysis, Hep-B virus infection, Hep-C virus infection, CMV infection, fasting blood 
sugar, serum total cholesterol, serum triglyceride, urine routine, graft type, induction 
therapy, recovery of graft function, acute rejection history, immunosuppressant 
regimen, type of complications were analysed. 
RESULTS: Out of 115 patients studied, 26 patients developed NODAT which 
accounts to a prevalence of 22.6%. 20 patients developed NODAT within a year 
following transplantation. The mean age of the patients who developed NODAT was 
35.23 years. Majority of the patients who underwent renal transplantation were males. 
Native kidney disease was not known in majority of the subjects and most of the 
patients were on hemodialysis. 3 patients who were positive for CMV developed 
NODAT. Most of the patients underwent live related renal transplantation. Older age, 
positive smoking history, family history of diabetes, acute rejection history, post 
transplant blood sugar levels, dose of Tacrolimus and prednisilone used as a part of 
immunosuppressive regimen were found to be significant associated with NODAT. 
Both community acquired and opportunistic infection rates were high in NODAT 
patients compared with N-NODAT patients.  
CONCLUSIONS: The prevalence of NODAT in our setup was 22.6%. Older age, 
positive smoking history, family history of diabetes, acute rejection history, post 
transplant blood sugar levels, dose of Tacrolimus and prednisilone used were all 
concluded to be significant risk factors contributing to the pathogenesis of NODAT. 
The pattern of NODAT was not different whether the transplant is live related or 
deceased donor. Bacterial pneumonia, CMV infections and fungal infections were 
common in patients with NODAT. Hence modification of certain modifiable risk 
factors can decrease the incidence of NODAT and also individuals at increased risk 
can be identified and screened earlier and managed appropriately. 
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